Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Hematologic Neoplasms 2Retinoblastoma 1Neutropenia 1Neoplasms 1

Interventions

Cyclophosphamide 72fludarabine 65Tacrolimus 43fludarabine phosphate 40Whole-Body Irradiation 37Mycophenolic Acid 35Busulfan 32Melphalan 28Antilymphocyte Serum 23thymoglobulin 22Thiotepa 20Methotrexate 20Standard of Care 19Stem Cell Transplantation 17Practice Guidelines as Topic 17Granulocyte Colony-Stimulating Factor 17Rituximab 15Surveys and Questionnaires 12Sirolimus 12Filgrastim 12Interviews as Topic 11Cyclosporine 11Blood Specimen Collection 11Peripheral Blood Stem Cell Transplantation 10Exercise 10venetoclax 9Mesna 9Cytarabine 9Bortezomib 9Hematopoietic Stem Cell Transplantation 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Hematologic Neoplasms × Anti-Infective Agents × Clear all
NCT03844360 2025-03-30

Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease

Shandong University

Phase 4 Recruiting
1,500 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT01821456 2013-04-01

CoCoNut

University Hospital of Cologne

Recruiting
100,000 enrolled
Other hematologic neoplasm

Neoplasms, Neutropenia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡